Dengue fever: diagnosis and treatment

References

• Menard B. Geographic changes in exposure to dengue. Sante13, 89–94 (2003).
   PubMedGoogle Scholar
• Pinheiro FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat. Q.50, 161–169 (1997).
   PubMedGoogle Scholar
• Shah I, Deshpande GC, Tardeja PN. Outbreak of dengue in Mumbai and predictive markers for dengue shock syndrome. J. Trop. Pediatr.50, 301–305 (2004).
   PubMed Web of Science ®Google Scholar
• Zhoa Z. Current status in the prevention and control of dengue fever in China. Zhonghua Liu Xing Bing Xue Za Zhi21, 223–224 (2000).
   PubMedGoogle Scholar
• Luo H, He J, Zheng K, Li L, Jiang L. Analysis on the epidemiologic features of Dengue fever in Guangdong province, 1990–2000. Zhonghua Liu Xing Bing Xue Za Zhi23, 427–430 (2002).
   PubMedGoogle Scholar
• Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect.2, 1693–1704 (2000).
   PubMed Web of Science ®Google Scholar
• Hills SL, Piispanen JP, Humphreys JL, Foley PN. A focal, rapidly controlled outbreak of dengue fever in two suburbs in Townsville, North Queensland, 2001. Commun. Dis. Intell.26, 596–600 (2001).
   Google Scholar
• Malcolm RL, Hanna JN, Phillips DA. The timeliness of notification of clinically suspected cases of dengue imported into north Queensland. Aust. NZ J. Public Health23, 414–417 (1999).
   PubMed Web of Science ®Google Scholar
• DeHart RL. Health issues of air travel. Annu. Rev. Public Health24, 133–151 (2003).
   PubMed Web of Science ®Google Scholar
• Reiskind MH, Baisley KJ, Calampa C, Sharp TW, Watts DM, Wilson ML. Epidemiological and ecological characteristics of past dengue virus infection in Santa Clara, Peru. Trop. Med. Int. Health6, 212–218 (2001).
   PubMed Web of Science ®Google Scholar
• Vaughn DW. Invited commentary: dengue lessons from Cuba. Am. J. Epidemiol.152, 800–803 (2000).
   PubMed Web of Science ®Google Scholar
• Haas W, Krause G, Marcus U, Stark K, Ammon A, Burger R. ]“Emerging infectious diseases”: dengue-fever, West-Nile-fever, SARS, avian influenza, HIV.] Internist. (Berlin)45, 684–692 (2004).
   PubMedGoogle Scholar
• Badiaga S, Barrau K, Brouqui P et al. Infectio-Sud Group. Imported dengue in French university hospitals: a 6-year survey. J. Travel Med.10, 286–289 (2003).
   PubMedGoogle Scholar
• Gascon J, Giner V, Vidal J, Jou JM, Mas E, Corachan M. Dengue: a re-emerging disease. A clinical and epidemiological study in 57 Spanish travelers. Med. Clin. (Barc.)111, 583–586 (1998).
   PubMedGoogle Scholar
• Fagbami AH, Monath TP, Fabiyi A. Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans. R. Soc. Trop. Med. Hyg.71, 60–65 (1977).
   PubMedGoogle Scholar
• Gubler DJ, Sather GE, Kuno G, Cabral JR. Dengue 3 virus transmission in Africa. Am. J. Trop. Med. Hyg.35, 1280–1284 (1986).
   PubMedGoogle Scholar
• Rodier GR, Parra JP, Kamil M, Chakib SO, Cope SE. Recurrence and emergence of infectious diseases in Djibouti city. Bull. World Health Organ.73, 755–759 (1995).
   PubMedGoogle Scholar
• Barboza P, Tarantola A, Lassel L, Mollet T, Quatresous I, Paquet C. Emerging viral infections in South East Asia and the Pacific region. Med. Mal. Infect.38, 513–523 (2008).
   PubMedGoogle Scholar
• Pinheiro FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat. Q.50, 161–169 (1997).
   PubMedGoogle Scholar
• Degallier N, Herve JP, Travassos da Rosa AP, Sa GC. Aedes aegypti (L.): importance of its bioecology in the transmission of dengue and other arboviruses. I Bull. Soc. Pathol. Exot. Filiales81, 97–110 (1988).
   PubMed Web of Science ®Google Scholar
• Mitrakul C. Bleeding problem in dengue haemorrhagic fever: platelets and coagulation changes. Southeast Asian J. Trop. Med. Public Health18, 407–412 (1987).
   PubMedGoogle Scholar
• Falconar AK. Dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol.142, 897–916 (1997).
   PubMed Web of Science ®Google Scholar
• Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology213, 254–257 (1995).
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. Dengue virus nonstructural-1 protein and its phylogenetic correlation to human fibrinogen and thrombocytes: a study to explain hemorrhagic complication. Int. J. Genom. Proteomics1, 2 (2004).
   Google Scholar
• Wiwanitkit V. Platelet CD61 might have an important role in causing hemorrhagic complication in dengue infection. Clin. Appl. Thromb. Hemost.11, 112 (2005).
   PubMedGoogle Scholar
• Wiwanitkit V. A study on functional similarity between dengue non structural protein 1 and platelet integrin/adhesin protein, CD61. J. Ayub. Med. Coll. Abbottabad.18, 13–16 (2006).
   PubMedGoogle Scholar
• Wiwanitkit V. Weak binding affinity of immunoglobin G, an explanation for the immune mimicking theory in pathophysiologic findings in the recovery phase of dengue. Nanomedicine1, 239–240 (2005).
   PubMedGoogle Scholar
• Wiwanitkit V. Bleeding and other presentations in Thai patients with dengue infection. Clin. Appl. Thromb. Hemost.10, 397–398 (2004).
   PubMedGoogle Scholar
• Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J. Clin. Virol.27, 1–13 (2003).
   PubMed Web of Science ®Google Scholar
• Guzman MG, Kouri G. Dengue: an update. Lancet Infect. Dis.2, 33–42 (2002).
   PubMed Web of Science ®Google Scholar
• da Fonseca BA, Fonseca SN. Dengue virus infections. Curr. Opin. Pediatr.14, 67–71 (2002).
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. Magnitude and pattern of pulmonary pathology in fatal cases of dengue hemorrhagic fever in Thailand. Int. J. Tuberc. Lung Dis.9, 1060 (2005).
   PubMedGoogle Scholar
• Wiwanitkit V. The tourniquet test is still a good screening tool for dengue illness. Trop. Doct.35, 127–128 (2005).
   PubMedGoogle Scholar
• Cao X T, Ngo TN, Wills B et al. Paediatric Hospital Study Group. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Vietnam. Trop. Med. Int. Health7, 125–132 (2002).
   PubMedGoogle Scholar
• Kowitdamrong E, Thammaborvorn R, Semboonlor L, Mungmee V, Bhattarakosol P. Detection of dengue HI and IgM antibody: is it diagnostically useful? When and how? J. Med. Assoc. Thai84(Suppl. 1), S148–S154 (2001).
   PubMedGoogle Scholar
• Schilling S, Ludolfs D, Van An L, Schmitz H. Laboratory diagnosis of primary and secondary dengue infection. J. Clin. Virol.31, 179–184 (2004).
   PubMed Web of Science ®Google Scholar
• Conceição TM, Da Poian AT, Sorgine MH. A real-time PCR procedure for detection of dengue virus serotypes 1, 2, and 3, and their quantitation in clinical and laboratory samples. J. Virol. Methods163, 1–9 (2010).
   PubMedGoogle Scholar
• De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz. J. Infect. Dis.8, 390–398 (2004).
   PubMedGoogle Scholar
• De Paula SO, Lopes da Fonseca BA. Optimizing dengue diagnosis by RT-PCR in IgM-positive samples: comparison of whole blood, buffy-coat and serum as clinical samples. J. Virol. Methods102, 113–117 (2002).
   PubMedGoogle Scholar
• Teles FR, Prazeres DM, Lima-Filho JL. Trends in dengue diagnosis. Rev. Med. Virol.15, 287–302 (2005).
   PubMed Web of Science ®Google Scholar
• Guzmán MG, Kourí G. Dengue diagnosis, advances and challenges. Int. J. Infect. Dis.8, 69–80 (2004).
   PubMed Web of Science ®Google Scholar
• Peyrefitte CN, Pastorino B, Bessaud M, Tolou HJ, Couissinier-Paris P. Evidence for in vitro falsely-primed cDNAs that prevent specific detection of virus negative strand RNAs in dengue-infected cells: improvement by tagged RT-PCR. J. Virol. Methods113, 19–28 (2003).
   PubMed Web of Science ®Google Scholar
• Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect. Dis.4, 337–348 (2004).
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. Nanomedicine: diagnosis to therapy. Asian Pac. J. Trop. Med.1, 68–70 (2008).
   Google Scholar
• Lee YF, Lien KY, Lei HY, Lee GB. An integrated microfluidic system for rapid diagnosis of dengue virus infection. Biosens. Bioelectron.25, 745–752 (2009).
   PubMed Web of Science ®Google Scholar
• Park SM, Huh YS, Craighead HG, Erickson D. A method for nanofluidic device prototyping using elastomeric collapse. Proc. Natl Acad. Sci. USA106, 15549–15554 (2009).
   PubMedGoogle Scholar
• Lien KY, Lee WC, Lei HY, Lee GB. Integrated reverse transcription polymerase chain reaction systems for virus detection. Biosens. Bioelectron.22, 1739–1748 (2007).
   PubMed Web of Science ®Google Scholar
• Misiano DR, Meyerhoff ME, Collison M. Current and future directions in the technology relating to bedside testing of critically ill patients. Chest97(5 Suppl.), S204–S214 (1990).
   PubMedGoogle Scholar
• Huang JL, Huang JH, Shyu RH et al. High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen. J. Med. Virol.65, 553–560 (2001).
   PubMedGoogle Scholar
• Wu TZ, Su CC, Chen LK, Yang HH, Tai DF, Peng KC. Piezoelectric immunochip for the detection of dengue fever in viremia phase. Biosens. Bioelectron.15, 689–695 (2005).
   Google Scholar
• Soni A, Chugh K, Sachdev A, Gupta D. Management of dengue fever in ICU. Indian J. Pediatr.68, 1051–1055 (2001).
   PubMedGoogle Scholar
• Ngo NT, Cao XT, Kneen R et al. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin. Infect. Dis.32, 204–213 (2001).
   PubMed Web of Science ®Google Scholar
• Damonte EB, Matulewicz MC, Cerezo AS. Sulfated seaweed polysaccharides as antiviral agents. Curr. Med. Chem.11, 2399–2419 (2004).
   PubMed Web of Science ®Google Scholar
• Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavirin, 6–azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res.58, 73–79 (2003).
   PubMed Web of Science ®Google Scholar
• Yin Z, Chen YL, Schul W et al. An adenosine nucleoside inhibitor of dengue virus. Proc. Natl Acad. Sci. USA106, 20435–20439 (2009).
   PubMed Web of Science ®Google Scholar
• Lescar J, Luo D, Xu T et al. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from dengue virus as a target. Antiviral Res.80, 94–101 (2008).
   PubMed Web of Science ®Google Scholar
• Frecer V, Miertus S. Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of dengue virus NS2B-NS3 protease. J. Comput. Aided Mol. Des.24(3), 195–212 (2010).
   PubMed Web of Science ®Google Scholar
• Che P, Wang L, Li Q. The development, optimization and validation of an assay for high throughput antiviral drug screening against dengue virus. Int. J. Clin. Exp. Med.8, 363–373 (2009).
   Google Scholar